TIME-COURSE OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD)-INDUCED THYMIC ATROPHY IN THE WISTAR RAT

被引:43
作者
DEHEER, C
VERLAAN, APJ
PENNINKS, AH
VOS, JG
SCHUURMAN, HJ
VANLOVEREN, H
机构
[1] UNIV UTRECHT,TOXICOL RES INST,3508 TD UTRECHT,NETHERLANDS
[2] TNO,INST TOXICOL & NUTR,3700 AJ ZEIST,NETHERLANDS
[3] SANDOZ PHARMA AG,PRECLIN RES IMMUNOL,BASEL,SWITZERLAND
关键词
D O I
10.1006/taap.1994.1185
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposure to sublethal doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in Wistar rats results in thymic atrophy and reduced thymic cellularity. In a first experiment, rats were once orally intubated with 0, 1, 5, 25, 50, and 150 mu g TCDD/kg body wt and sacrificed at Day 10. The dose that produced one-half of the maximal thymic involution was estimated at about 10-20 mu g/kg. The time course (Days 0-21) of thymic atrophy induced by a single oral intubation of 25 mu g TCDD/kg body wt revealed four phases. In phase 1 (initiation phase, Days 0-2) a decrease in proliferative activity was seen in cortical thymocytes, whereas no changes occurred in thymic cellularity. Phase 2 (lymphodepletion phase, Days 2-8) was characterized by an initial strong depletion of immature CD4(+)CD8(+) double-positive (DP) cells (Day 4), followed by a more gradual decrease in the number of mature thymocytes (Day 6). On Day 8 the lymphodepletion was maximal. In phase 3 (stationary phase, Days 8-13) no changes occurred in thymic cellularity. Although the first signs of recovery were already seen on Day 6, indicated by a recovery in proliferative activity in the thymus cortex, an increase in thymic cellularity was observed first after Day 13 (phase 4, recovery phase, Day 13 onward). Reversibility of thymic atrophy is therefore observed within the estimated half-life of TCDD in the rat thymus (>16 days). We conclude that TCDD exerts a rapidly reversible effect on an intrathymic cortical target cell population. (C) 1994 Academic Press, Inc.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 33 条
  • [1] RAT MONOCLONAL-ANTIBODIES .1. RAPID PURIFICATION FROM INVITRO CULTURE SUPERNATANTS
    BAZIN, H
    XHURDEBISE, LM
    BURTONBOY, G
    LEBACQ, AM
    DECLERCQ, L
    CORMONT, F
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 66 (02) : 261 - 269
  • [2] EXPOSURE TO TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) ALTERS FETAL THYMOCYTE MATURATION
    BLAYLOCK, BL
    HOLLADAY, SD
    COMMENT, CE
    HEINDEL, JJ
    LUSTER, MI
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 112 (02) : 207 - 213
  • [3] 2 SUBSETS OF RAT LYMPHOCYTES-T DEFINED WITH MONOCLONAL-ANTIBODIES
    BRIDEAU, RJ
    CARTER, PB
    MCMASTER, WR
    MASON, DW
    WILLIAMS, AF
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (08) : 609 - 615
  • [4] AN INVITRO MODEL FOR STUDYING THE TOXICITY OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN TO HUMAN THYMUS
    COOK, JC
    DOLD, KM
    GREENLEE, WF
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 89 (02) : 256 - 268
  • [5] MRC OX-19 - A MONOCLONAL-ANTIBODY THAT LABELS RAT LYMPHOCYTES-T AND AUGMENTS INVITRO PROLIFERATIVE RESPONSES
    DALLMAN, MJ
    THOMAS, ML
    GREEN, JR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (03) : 260 - 267
  • [6] ULTRASTRUCTURE OF THE CORTICAL EPITHELIUM OF THE RAT THYMUS AFTER IN-VIVO EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD)
    DEWAAL, EJ
    RADEMAKERS, LHPM
    SCHUURMAN, HJ
    VANLOVEREN, H
    VOS, JG
    [J]. ARCHIVES OF TOXICOLOGY, 1993, 67 (08) : 558 - 564
  • [7] ALTERATIONS IN THE CORTICAL THYMIC EPITHELIUM OF RATS AFTER INVIVO EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) - AN (IMMUNO)HISTOLOGICAL STUDY
    DEWAAL, EJ
    SCHUURMAN, HJ
    LOEBER, JG
    VANLOVEREN, H
    VOS, JG
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 115 (01) : 80 - 88
  • [8] TOXICOLOGICAL AND PATHOLOGICAL APPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA), A NOVEL ENDOGENOUS MARKER FOR CELL-PROLIFERATION
    DIETRICH, DR
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1993, 23 (01) : 77 - 109
  • [9] DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
  • [10] ONTOGENIC DEVELOPMENT OF MURINE FETAL THYMOCYTES IS ACCELERATED BY 3,3',4,4'-TETRACHLOROBIPHENYL
    ESSER, C
    WELZEL, M
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (08): : 841 - 852